Prolactinoma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 18: Line 18:
*I: Enclosed within the [[sella turcica]], microadenoma, smaller than 10 mm
*I: Enclosed within the [[sella turcica]], microadenoma, smaller than 10 mm
*II: Enclosed within the [[sella turcica]], macroadenoma, 10 mm or larger
*II: Enclosed within the [[sella turcica]], macroadenoma, 10 mm or larger
*III: Invasive, locally, into the sella
*III: Invasive, locally, into the [[sella]]
*IV: Invasive, diffusely, into the sella
*IV: Invasive, diffusely, into the [[sella]]
The grading scheme for suprasellar extensions is as follows:
The grading scheme for suprasellar extensions is as follows:
*A: 0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
*A: 0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
*B: 10 mm  to 20 mm extension and elevation of the third [[ventricle]]
*B: 10 mm  to 20 mm extension and elevation of the [[third ventricle]]
*C: 20 mm to 30 mm extension occupying the [[anterior]] of the third [[ventricle]]
*C: 20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]]
*D: A larger than 30 mm extension, beyond the [[foramen]] of Monro, or Grade C with lateral extensions
*D: A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions


== References ==
== References ==

Revision as of 20:47, 18 July 2017

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma classification

CDC on Prolactinoma classification

Prolactinoma classification in the news

Blogs on Prolactinoma classification

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Prolactinoma can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).

Classification

Prolactinoma may be classified based on either size or local invasion.

Classification based on size

Based on size, a prolactinoma can be classified as:

  • Microprolactinoma (<10 mm diameter)
  • Macroprolactinoma (>10 mm diameter)

Classificatioin based on local invasion[1][2][3]

The classification for pituitary adenomas is as follows:

  • 0: Normal pituitary appearance
  • I: Enclosed within the sella turcica, microadenoma, smaller than 10 mm
  • II: Enclosed within the sella turcica, macroadenoma, 10 mm or larger
  • III: Invasive, locally, into the sella
  • IV: Invasive, diffusely, into the sella

The grading scheme for suprasellar extensions is as follows:

References

  1. "Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute".
  2. Yeh PJ, Chen JW (1997). "Pituitary tumors: surgical and medical management". Surg Oncol. 6 (2): 67–92. PMID 09436654.
  3. Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98

Template:WikiDoc Sources